Besides, asparaginase in RBCs is also used in patients with PEG-asparaginase allergy (NCT03267030, phase II) and lymphoblastoma (NCT01910428, phase I) and pancreatic adenocarcinoma (NCT01523808, phase I and NCT02195180, phase II). Here, ASPG is linked to pancreatic adenocarcinoma.